Icteric non-hemolitic newborns. Neonatal jaundice, unspecified
Conditions
Interventions
Intervention 1: Group1: prescribed 100 mg /kg clofibrate orally as single dose on arrival, in addition to phototerapy for 3 days. Intervention 2: Group 2: prescribed 5 mg /kg phenobarbital orally as
Treatment - Drugs
Placebo
Group1: prescribed 100 mg /kg clofibrate orally as single dose on arrival, in addition to phototerapy for 3 days.
Group 2: prescribed 5 mg /kg phenobarbital orally as single dose on arrival, in addition to phototerapy for 3 days.
Group 3: only reseaved distrilled water in addition to phototherapy for 3 days.
Sponsors
Shahrekord University of Medical Science
Eligibility
Sex/Gender
All
Age
No minimum to 1 Years
Inclusion criteria
Inclusion criteria: Iinclusion criteria:Parents permission; Infants with non-hemolytic icter; term neonates (37-42 weeks age); birth weight 2/5- 4kg; breast feeding only; indirect bilirubin level between 15-20 mg/dl on arrival; jaundice beginning at days 3-11 after birth; hematocrit level less than 65% or Hb under 20 Exclusion criteria: physical anomalies; previous remedy consumption; previous history of jaundice therapy; sepsis
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum bilirubin level. Timepoint: On arival and 12, 24, 48 and 72 hours after. Method of measurement: mg/dl. | — |
Secondary
| Measure | Time frame |
|---|---|
| Duration of hospitalization. Timepoint: Day. Method of measurement: Days beeing hospitalized. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Majid Hamidi
Shahrekord University of Medical Science
Outcome results
None listed